Form 4: Myriad Genetics CEO Paul J. Diaz Reports Stock Transactions
SEC Form 4 Filing
Paul J. Diaz, President and CEO of Myriad Genetics, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On August 13, 2024, Paul J. Diaz, the President and CEO of Myriad Genetics, had shares withheld by the company to cover tax obligations.
- A total of 22,808 shares were withheld at a price of $28.18 per share related to restricted stock units.
- An additional 50,980 shares were withheld at the same price of $28.18 per share related to performance-based restricted stock units.
- Following these transactions, Diaz directly owns 992,378 shares of Myriad Genetics.
Sentiment
Score: 5
Explanation: This is a neutral filing related to routine stock transactions for tax purposes. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This is a routine filing related to executive compensation and does not necessarily indicate a change in the company's outlook or performance. It is common for companies to withhold shares to cover tax obligations when restricted stock units vest.
Key Dates
| Date | Description |
|---|---|
| 08/13/2024 | Date of stock transactions (shares withheld for tax obligations). |
| 08/14/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.